Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the Mainland China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. Its Healthcare Business segment includes medical and healthcare services; hospital operations; import, export, and trading of medical-related goods; equipment life cycle management; medical digitalization services; and intelligent medical health and elder care. The company also provides medical and professional technology, financing, hospital management, medical consulting, sale of medical related goods, medical, software development, and elderly care services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. The company was founded in 1984 and is headquartered in Beijing, China.
Frequently asked questions
What sector does Universal Med Finl & (2666) operate in?
Universal Med Finl & belongs to the Healthcare sector and operates in the Credit Services industry.
What is Universal Med Finl & (2666) current stock price?
As of the latest data, Universal Med Finl & stock price is HK$4.53, with a previous close of HK$4.46. Universal Med Finl & gained HK$0.07 in the last trading session, representing a 1.57% increase.
What is Universal Med Finl & (2666) current market capitalization?
Universal Med Finl & market cap is approximately 9.11 billion.
What is Universal Med Finl & (2666) EBITDA?
Universal Med Finl & EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.13 billion.
Does Universal Med Finl & (2666) pay dividends?
Yes. Universal Med Finl & pays annual dividends with an annualized yield of 7.96% and an estimated annual payout of HK$0.36 per share.
When is the next ex-dividend date for Universal Med Finl & (2666)?
The next ex-dividend date is scheduled for June 26, 2027.
When is Universal Med Finl & (2666) next earnings report?
Universal Med Finl & is expected to release its next earnings report on December 31, 2026.
What is Universal Med Finl & (2666) beta (volatility) score?
Universal Med Finl & has a beta of 0.570, indicating lower volatility than the overall market.